Patent details

Basic Information

Publication number:

EP3102946

PCT Application Number:

EP2015052184

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157024829

PCT Publication Number:

WO2015117953

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DIAGNOSIS OF CANCER BY DETECTING AUTO-ANTIBODIES AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)

French Title of Invention:

DIAGNOSTIC DE CANCER PAR LA DÉTECTION D'AUTO-ANTICORPS CONTRE LE FACTEUR DE CROISSANCE ENDOTHÉLIALE VASCULAIRE (VEGF)

German Title of Invention:

DIAGNOSE VON KREBS DURCH DETEKTION VON AUTO-ANTIKÖRPERN GEGEN DEN VASKULÄREN ENDOTHELIALEN WACHSTUMSFAKTOR (VEGF)

SPC Number:

Dates

Filing date:

03/02/2015

Grant date:

31/10/2018

EP Publication Date:

14/12/2016

PCT Publication Date:

13/08/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

31/10/2018

EP B1 Publication Date:

31/10/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/02/2019

Expiration date:

03/02/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/10/2018

 

 

Name:

CellTrend GmbH

Address:

Im Biotechnologiepark, 14943 Luckenwalde, Germany (DE)

Inventor

1

Name:

HEIDECKE, Harald

Address:

Germany (DE)

2

Name:

SCHULZE-FORSTER, Kai

Address:

Germany (DE)

Priority

Priority Number:

14153823

Priority Date:

04/02/2014

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61P 35/00; G01N 33/564; G01N 33/574;

Publication

European Patent Bulletin

Issue number:

201844

Publication date:

31/10/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages